These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17270285)

  • 1. Effects of valproic acid on hearing in epileptic patients.
    Incecik F; Akoglu E; Sangün O; Melek I; Duman T
    Int J Pediatr Otorhinolaryngol; 2007 Apr; 71(4):611-4. PubMed ID: 17270285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of valproic acid monotherapy on behavior and cognitive performance of children with idiopathic generalized epilepsy].
    Schmidt A; Darius J; Brosz M; Roth N; Meyer FP; Kroker S; Wien F; Brett B
    Z Kinder Jugendpsychiatr; 1995 Sep; 23(3):161-70. PubMed ID: 7571875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study.
    Attilakos A; Voudris KA; Garoufi A; Mastroyianni S; Dimou S; Prassouli A; Katsarou E
    Eur J Paediatr Neurol; 2006; 10(5-6):237-40. PubMed ID: 17035050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid.
    Korkmazer N; Vurucu S; Demirkaya E; Unay B; Kul M; Akin R; Gokcay E
    Brain Dev; 2006 Sep; 28(8):515-20. PubMed ID: 16682156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid.
    Arslan M; Vurucu S; Balamtekin N; Unay B; Akin R; Kurt I; Ozcan O
    Brain Dev; 2009 Jun; 31(6):405-10. PubMed ID: 18814980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid clearance in children with epilepsy.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I
    J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of fetal hemoglobin synthesis indicating differentiation induction in children receiving valproic acid.
    Kieslich M; Schwabe D; Cinatl J; Driever PH
    Pediatr Hematol Oncol; 2003; 20(1):15-22. PubMed ID: 12687749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experimental design for finding of minimum dosage of carbamazepine and valproate in preventing of seizure attacks.
    Samaei A; Nobahar M; Vafaei AA
    Pak J Pharm Sci; 2009 Apr; 22(2):180-3. PubMed ID: 19339229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
    Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitability of the human epileptic cortex after chronic valproate: a reappraisal.
    Cantello R; Civardi C; Varrasi C; Vicentini R; Cecchin M; Boccagni C; Monaco F
    Brain Res; 2006 Jul; 1099(1):160-6. PubMed ID: 16774745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.
    Dutta S; Reed RC
    J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-induced reversible sensorineural hearing loss: a case report with serial audiometry and pharmacokinetic modelling during a valproate rechallenge.
    Yeap LL; Lim KS; Lo YL; Bakar MZ; Tan CT
    Epileptic Disord; 2014 Sep; 16(3):375-9. PubMed ID: 25167568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy.
    Vurucu S; Demirkaya E; Kul M; Unay B; Gul D; Akin R; Gokçay E
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):844-8. PubMed ID: 18234410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.
    Gorkemli H; Genc BO; Dogan EA; Genc E; Ozdemir S
    Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
    Ugras M; Yakinci C
    Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study.
    Attilakos A; Katsarou E; Prassouli A; Mastroyianni S; Voudris K; Fotinou A; Garoufi A
    Clin Neuropharmacol; 2009; 32(1):32-4. PubMed ID: 18978499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.